Detected ·
Biograil™
€20M—
Copenhagen-based biotech Biograil™ has closed a €20M financing round to advance its Phase 1 clinical trial preparations for BIONDD®, an oral drug delivery device. The round was backed by Verve Ventures, MEGATREND INVEST A/S, and HTGF.
- Website
- —
- linkedin.com/company/73462820
- Amount
- €20 000 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-04 16:09:04 UTC
- Signal ID
- 813e4d1f-516f-41ca-9868-64d7f13f3d06
As the API returns it
{
"id": "813e4d1f-516f-41ca-9868-64d7f13f3d06",
"created_at": "2026-11-04T16:09:04.412271Z",
"company_name": "Biograil™",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/73462820",
"event_type": "funding",
"funding_amount": 20000000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*Copenhagen-based biotech Biograil™ has closed a €20M financing round to advance its Phase 1 clinical trial preparations for BIONDD®, an oral drug delivery device. The round was backed by Verve Ventures, MEGATREND INVEST A/S, and HTGF.*"
}